Evidence for isoxicam binding to site I as a primary site and to site II as a secondary site of human serum albumin.
Isoxicam binding to HSA was studied using equilibrium dialysis and fluorescence methods. It was shown that this drug binds to or near site I (warfarin or azapropazone site) and to site II (the diazepam site) as a secondary site, although it is generally considered that their respective drug structural requirements are often exclusive. The binding parameters were calculated with different mathematical models; a site oriented model with or without fixing the number of binding sites as integer values and a stoichiometric model. The relevant results are in good agreement under the selected experimental conditions. The stoichiometric method indicates that no positive cooperativity occurred during the binding process but other interactions between the two sites cannot be excluded.
Bree
F
F
Laboratoire de Pharmacologie, Faculté de Médecine, Creteil, France.
Nguyen
P
P
Albengres
E
E
Urien
S
S
Riant
P
P
Welling
P G
PG
Tillement
J P
JP
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism*; D001665:Binding Sites; D005453:Fluorescence; D006801:Humans; D010894:Piroxicam / Q000031:analogs & derivatives* / Q000378:metabolism; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012709:Serum Albumin; D010894:Piroxicam; C013580:isoxicam